EmeraMed: Targeting the cause of diseases.
Oxidative stress releases free radicals and is a major part of all illnesses. Emeramide captures free radicals, which are unstable molecules that can damage the cells in your body. Additionally Emeramide captures the heavy metals mercury and iron which would otherwise create free radicals. Emeramide thereby helps restore normal function to the mitochondria and overall health.
COPD: A Phase 2a clinical trial has been completed in summer of 2018 and found Emeramide to be safe with no adverse effects.
Other conditions: Preclinical studies are ongoing for several other indications.
- Covid-19: Due to Covid-19’s association with oxidative stress and high iron levels, Emeramide is ideally suited to treat Covid-19. Studies are underway to support our belief that Emeramide contributes to the treatment of Covid-19.
Latest Information
Emeramide, a safe metals chelator and antioxidant
Emeramide is an exceptionally safe and effective lipophilic, blood-brain-barrier passing metal chelator and antioxidant being developed by EmeraMed Limited. It is currently going through the European Medical Agency (EMA) and the United States Food and Drug Administration (FDA) drug approval process.
Warning: Counterfeit Emeramide sold illegally in EU & USA
Counterfeit Emeramide is being sold under our various trade names (OSR#1, NBMI, emeramide) and tests have shown that it is not emeramide. This is unsafe and illegal and we are continuously in contact with the various regulatory authorities to take action.
Study results from mercury poisoned gold miners
Mercury chelator Emeramide produced outstanding results in safety and efficacy despite the fact that gold miners were overwhelmed with continuous mercury exposure.
English
Chinese (Simplified)
Chinese (Traditional)
French
German
Italian
Japanese
Maori
Portuguese
Russian
Spanish
Swedish